SCHEMBL8686643

SCHEMBL8686643

N#Cc1cccc(Cn2ccc3c(/C=C4\SC(=O)NC4=O)cccc32)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.58
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
TTR P02766 2/20 0.45
AKR1B1 P15121 1/20 0.45
APP P05067 3/20 0.43
PTPN1 P18031 1/20 0.42
NPM1 P06748 1/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
BLM P54132 1/20 0.41
PLA2G1B P04054 1/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
SNCA P37840 2/20 0.40
HPGD P15428 1/20 0.40
PIM1 P11309 1/20 0.39
PIM3 Q86V86 1/20 0.39
PIM2 Q9P1W9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8810605 1.00 PARP1 (0.58) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8690518 0.90 PARP1 (0.57) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8810593 0.90 PARP1 (0.57) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8685564 0.89 PARP1 (0.74) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8810613 0.89 PARP1 (0.44) PARP1APPNPM1SNCA
SCHEMBL8811256 0.89 PARP1 (0.74) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8809167 0.86 PARP1 (0.62) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8685371 0.86 PARP1 (0.62) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8685959 0.86 PARP1 (0.66) PARP1MEN1KMT2ATTRAKR1B1
SCHEMBL8685962 0.86 PARP1 (0.66) PARP1MEN1KMT2ATTRAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed